Trial intelligence / Profile preview

Multicenter randomized study of multi-concentration sodium hyaluronate in dry eye syndrome

KCT0001796Phase 4Completed

Sponsor
Taejoon Pharmaceutical Co., Ltd.
Start
Jul 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of sodium hyaluronate in dry eye syndrome (DED), sponsored by Taejoon Pharmaceutical Co., Ltd.. Started Jul 2014; status: completed.

02

Drugs

sodium hyaluronate
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on KCT0001796.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001796.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call